All Interventions

    Red Light Therapy

    Devices
    Photobiomodulation

    Therapeutic exposure to red (630-660nm) and near-infrared (810-850nm) light to enhance mitochondrial function and tissue healing.

    Evidence Summary

    8
    / 10Score
    Moderate
    Good Clinical Evidence

    Red-light and near-infrared photobiomodulation has one of the largest human evidence bases among longevity devices — strongest for skin, wound healing, and pain, and increasingly supported for exercise recovery and performance. Two 2024-2025 meta-analyses of randomized trials found small-to-moderate, consistent benefits. A 2024 meta-analysis in Lasers in Medical Science (34 RCTs) reported that pre-exercise photobiomodulation improved muscle endurance (standardized mean difference 0.31, 95% CI 0.11-0.51), improved muscle-strength recovery (SMD 0.24, 95% CI 0.10-0.39), and reduced post-exercise creatine kinase, a marker of muscle damage (mean difference -77.6 U/L, 95% CI -112.7 to -42.4); benefit appeared in athletes and sedentary adults but not in already-active individuals. A 2022 Sports Medicine meta-analysis (37 studies, 586 participants) showed the effect is mode-specific — significant for single-joint muscle endurance (SMD 0.27) and cycling time-to-exhaustion (SMD 0.35), but not for maximal strength or all-out sprints. A 2025 systematic review of whole-body photobiomodulation and a 2025 meta-analysis of photomodulation for delayed-onset muscle soreness point the same direction while emphasizing device, wavelength, and dose heterogeneity. For skin, controlled trials show red/near-infrared light can increase intradermal collagen density and reduce fine lines. Evidence quality is moderate: many trials are small, short, and use varied protocols, so device power density, wavelength, distance, and consistency strongly influence outcomes. Educational information, not medical advice.

    Evidence Scale

    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    AnecdotalStrong RCT

    Mechanism of Action

    Red (630-660 nm) and near-infrared (810-850 nm) photons are absorbed by cytochrome c oxidase (complex IV) of the mitochondrial respiratory chain. This is thought to transiently dissociate inhibitory nitric oxide, increase electron transport and ATP synthesis, and trigger a brief, hormetic burst of reactive oxygen species that activates cytoprotective signaling (e.g. Nrf2). Downstream effects include improved local blood flow, modulation of inflammation, and stimulation of fibroblast collagen synthesis and tissue repair.

    Who Is This For?

    Skin health, muscle recovery, pain reduction, mitochondrial support, hair growth, wound healing.

    Protocol & Dosing

    Dose

    10-20 minutes per area. Irradiance commonly 10-100 mW/cm2 at the skin; total fluence typically a few to tens of J/cm2. Treatment distance per device specifications. 3-5 sessions per week. Use eye protection for facial treatment. More is not always better — very high doses can blunt the effect (biphasic dose response).

    Frequency

    Daily to every other day

    Duration

    Ongoing

    Protocol Summary

    Panel or targeted LED/laser exposure to bare skin over the target area. Typical sessions are 10-20 minutes per area, 3-5 times per week, with wavelength (red for surface/skin, near-infrared for deeper muscle and joint tissue), irradiance (power density), and treatment distance matched to the device. For recovery and performance, current evidence favours dosing shortly before or soon after exercise. Total delivered dose (fluence) is the key variable, and consistency matters more than any single long session.

    Latest Evidence

    2024-2025: photobiomodulation's clearest wins are endurance and recovery

    A 2024 meta-analysis of 34 randomized trials (Lasers in Medical Science) found that photobiomodulation delivered before exercise produced small-to-moderate improvements in muscle endurance (standardized mean difference 0.31, 95% CI 0.11-0.51) and in muscle-strength recovery (SMD 0.24, 95% CI 0.10-0.39), and reduced post-exercise creatine kinase — a marker of muscle damage — by a mean of about 78 U/L (95% CI -112.7 to -42.4). Benefit was seen in athletes and in sedentary adults, but not in people who were already highly active.

    A 2022 Sports Medicine meta-analysis (37 studies, 586 participants) shows the effect is mode-specific: significant for single-joint muscle endurance (SMD 0.27) and cycling time-to-exhaustion (SMD 0.35), but not for maximal strength or all-out sprints. A 2025 systematic review of whole-body photobiomodulation and a 2025 meta-analysis of photomodulation for delayed-onset muscle soreness point in the same direction. For skin, controlled trials show red and near-infrared light can raise intradermal collagen density and soften fine lines.

    Effects are modest and the trials are heterogeneous — device wavelength, irradiance (power density), distance, and total dose strongly shape outcomes, and more is not always better (a biphasic dose response). Screen for photosensitizing medications and avoid treating over active malignancy. Educational information, not medical advice.

    2 meta-analyses · standardized effect (SMD) vs sham · higher = better

    Photobiomodulation's edge is in endurance and recovery — small but consistent

    Bars show the pooled standardized mean difference (SMD) in each outcome versus sham light; whiskers are 95% confidence intervals. Teal bars are from a 2024 meta-analysis of 34 pre-exercise photobiomodulation RCTs (Lasers in Medical Science); the other two are from a 2022 mode-specific meta-analysis of 37 studies / 586 participants (Sports Medicine). All four effects reached significance (p<0.01). The same 2024 analysis also found a reduction in post-exercise creatine kinase (mean difference -77.6 U/L, 95% CI -112.7 to -42.4). Effects are small-to-moderate and strongest for endurance-type and recovery outcomes rather than maximal strength or sprints. Educational information, not proof of benefit for any individual.

    Key references: Pre-exercise photobiomodulation for muscle endurance & recovery — meta-analysis of RCTs, Lasers in Medical Science (2024) · Deconstructing the ergogenic effects of photobiomodulation — Sports Medicine (2022) · Whole-body photobiomodulation for exercise performance & recovery — systematic review, Lasers in Medical Science (2025) · Photomodulation therapy for delayed-onset muscle soreness — meta-analysis, J. Funct. Morphol. Kinesiol. (2025)

    Interactions & Precautions

    Contraindications

    • Photosensitizing medications
    • Active cancer at treatment site
    • Pregnancy (limited data)

    Potential Risks

    • •Limited quality control in devices
    • •Inconsistent protocols

    Potential Side Effects

    Rare: temporary visual disturbance if used on face without eye protection

    Practitioner Notes

    Clinical annotations from Dr. Goel

    Device quality and dose matter enormously — look for verified irradiance (mW/cm2) at a stated distance, not just LED count. Use red (~630-660 nm) for surface and skin effects and near-infrared (~810-850 nm) for deeper muscle and joint tissue. For recovery, dose near training; respect the biphasic dose response (very high fluence can reduce benefit). Consistency beats session length. Screen for photosensitizing medications, avoid treating over active malignancy, and protect the eyes during facial use.
    SG

    Dr. Sanjeev Goel

    Chief Medical Officer, Peak Human

    Cost & Access

    Cost Range

    $$

    Accessibility

    Home devices widely available

    Availability varies by location

    PHS
    671
    / 1000
    T3
    Longevity Operator

    Sample member

    Longevity Operator

    The Peak Human Score · PHS v1

    One number for your longevity journey.

    FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.

    • Metabolic
    • Hormonal
    • Cardiovascular
    • Brain / Cognitive
    • Sleep
    • Musculoskeletal
    • Gut
    • Immunity / Inflammation